More Globe Newswire

View Older Stories View Newer Stories

Nov 4, 2024 01:00AM Investor Day 2024: Clariant well positioned for further growth and profitability improvement
Nov 4, 2024 01:00AM Arcadis reports transactions under its current share buyback program
Nov 4, 2024 12:28AM TBV and BitcoinOS to Host The Best Event at Devcon BKK: Exclusive Networking and Epic Afterparty
Nov 3, 2024 09:14PM Bitget Wallet Director Emphasizes the Ecosystem's Growth at TON Gateway in Dubai
Nov 3, 2024 09:14PM Bitget Wallet Director Emphasizes the Ecosystem's Growth at TON Gateway in Dubai
Nov 3, 2024 07:00PM Talen Energy Statement on FERC Order Rejecting Susquehanna ISA
Nov 3, 2024 05:03PM Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
Nov 3, 2024 04:30PM Complete Solar to Report Third Quarter Financial and Operational Results on November 13, 2024
Nov 3, 2024 04:00PM Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
Nov 3, 2024 08:32AM Robert A. and Elizabeth R. Jeffe Distinguished Lecture in Urban History: An Evening with Dr. Ned Blackhawk
Nov 2, 2024 06:00PM NN, Inc. Executive Management to Present at the Gabelli Funds 48th Annual Automotive Symposium
Nov 2, 2024 02:46PM Survey: Nearly Half of Americans Expect Their Mental Health to be Negatively Affected By the Presidential Election Result
Nov 2, 2024 11:07AM SPZI: JP3E Issues PR Clarification
Nov 2, 2024 11:03AM Walstreamz Set to Expand its E-commerce Solutions with the Launch of Ecom Private Label, eBay Automation, and TikTok Automation
Nov 2, 2024 11:03AM Titan Fund Management Services Expands Investment Offerings to Meet Growing Demand for Tailored Wealth Solutions
Nov 2, 2024 09:00AM Sermonix Surveys Find Vaginal/Sexual Health Symptoms Are Among Most Significant Issues Affecting Lives of ER+/HER2- Metastatic Breast Cancer Patients
Nov 2, 2024 09:00AM Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, Demonstrates Promising Ki67 Suppression in Phase 2 I-SPY 2 Arm Evaluating Therapy in Neoadjuvant Breast Cancer Setting
Nov 2, 2024 08:32AM Optimal Breathing Holds its Annual Black Friday Sale
Nov 2, 2024 06:26AM TD BANK has been Sued for Securities Fraud after Money Laundering Guilty Plea; Contact the Firm before December 23 Class Action Deadline (NYSE:TD)
Nov 2, 2024 06:23AM EDWARDS LIFESCIENCES has been Sued for Securities Fraud after Stock Plummets 31%; Contact the Firm before December 13 Class Action Deadline (NYSE:EW)
Nov 1, 2024 09:00PM CORRECTION - Bogota Financial Corp. Reports Results for the Three and Nine Months Ended September 30, 2024 Corrected
Nov 1, 2024 08:00PM Euro Sun Announces $2.15 Million Private Placement
Nov 1, 2024 07:41PM Fobi AI Responds To CTO (Cease Trade Order) Commitment To Financial Transparency and Audit Completion
Nov 1, 2024 07:35PM Paragon 28, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Distr
Nov 1, 2024 07:33PM Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws
Nov 1, 2024 07:31PM Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the North
Nov 1, 2024 07:30PM Madison Pacific Properties Inc. announces the results for the year ended August 31, 2024
Nov 1, 2024 07:29PM Xiao-I Corporation Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Sou
Nov 1, 2024 07:04PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 1, 2024 06:51PM Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
Nov 1, 2024 06:50PM First National Bank Alaska declares regular and special dividends for fourth quarter, both payable in December
Nov 1, 2024 06:49PM Revolutionizing Mental Health: Dr. Anna Yusim Integrates Spirituality, Psychedelics, and Conscious Leadership at Global Summits
Nov 1, 2024 06:35PM Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at October 31, 2024
Nov 1, 2024 06:34PM Trump Holds 7-point Lead Over Harris in Florida, New Stetson University Poll Finds
Nov 1, 2024 06:32PM LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 1, 2024 06:24PM Prime Drink Group Announces Closing of Triani Canada Acquisition
Nov 1, 2024 06:14PM HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
Nov 1, 2024 06:14PM HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
Nov 1, 2024 06:00PM Legible Announces Appointment of Successor Auditor
Nov 1, 2024 05:58PM Beasley Broadcast Group to Report 2024 Third Quarter Financial Results, Host Conference Call and Webcast on November 5
Nov 1, 2024 05:52PM Vinesign Launches Powerful Public API, Empowering Businesses to Seamlessly Integrate E-Signature Solutions into Their Workflow
Nov 1, 2024 05:49PM South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer
Nov 1, 2024 05:49PM South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer
Nov 1, 2024 05:43PM Nubian Grants Options
Nov 1, 2024 05:42PM DFW Metro Gains Fifth New Rally House Store in 2024
Nov 1, 2024 05:30PM OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
Nov 1, 2024 05:30PM ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
Nov 1, 2024 05:26PM NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 1, 2024 05:11PM CNL Strategic Capital Launches Second Follow-On Offering of $1.1 Billion
Nov 1, 2024 05:00PM Lumine Group Inc. Announces Results for the Three and Nine Months Ended September 30, 2024
View Newer Stories View Older Stories